CAS: 1802706-04-2
Sort by
Found 3 products.
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide
CAS:(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide is a drug candidate for the treatment of lymphocytic leukemia and other cancers. It has shown inhibitory effects on cardiac cells that are not present in primary cells or cancer cells. This drug also has been shown to have an antiangiogenic effect on pancreatic cancer and chronic lymphocytic leukemia. (7S)-N-[5-(ethylsulfonyl)-2-pyridinyl]methyl]-6, 7-dihydro-7-(1 -methylethyl)-6-[(trans, trans 4Formula:C27H35F3N4O3SPurity:Min. 95%Molecular weight:552.65 g/molVimirogant
CAS:Vimirogant is a RORγ inhibitor (Ki: <100 nM).Formula:C27H35F3N4O3SPurity:98%Color and Shape:SolidMolecular weight:552.65(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrrolo[3,4-b]pyridine-3-carboxamide
CAS:Controlled ProductFormula:C27H35F3N4O3SColor and Shape:NeatMolecular weight:552.652
![(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluor…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FCXC70604.jpg&w=3840&q=75)
![(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluor…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb%2FE890955.jpg&w=3840&q=75)
